BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 22768838)

  • 1. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.
    Imajo K; Fujita K; Yoneda M; Nozaki Y; Ogawa Y; Shinohara Y; Kato S; Mawatari H; Shibata W; Kitani H; Ikejima K; Kirikoshi H; Nakajima N; Saito S; Maeyama S; Watanabe S; Wada K; Nakajima A
    Cell Metab; 2012 Jul; 16(1):44-54. PubMed ID: 22768838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
    Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model for nonalcoholic steatohepatitis.
    Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C
    J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.
    Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM
    Hepatology; 2004 Aug; 40(2):434-41. PubMed ID: 15368448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
    Brun P; Castagliuolo I; Di Leo V; Buda A; Pinzani M; Palù G; Martines D
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G518-25. PubMed ID: 17023554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
    Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G762-72. PubMed ID: 22268099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model.
    Kudo H; Takahara T; Yata Y; Kawai K; Zhang W; Sugiyama T
    J Hepatol; 2009 Jul; 51(1):168-75. PubMed ID: 19446916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adipocytokines in hepatic fibrogenesis.
    Ikejima K; Okumura K; Kon K; Takei Y; Sato N
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S87-92. PubMed ID: 17567476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis.
    Chung MY; Yeung SF; Park HJ; Volek JS; Bruno RS
    J Nutr Biochem; 2010 Dec; 21(12):1200-6. PubMed ID: 20138495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
    J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
    J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.
    Li Z; Soloski MJ; Diehl AM
    Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.
    Begriche K; Massart J; Abbey-Toby A; Igoudjil A; Lettéron P; Fromenty B
    Obesity (Silver Spring); 2008 Sep; 16(9):2053-67. PubMed ID: 19186330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis.
    Gäbele E; Dostert K; Dorn C; Patsenker E; Stickel F; Hellerbrand C
    Alcohol Clin Exp Res; 2011 Jul; 35(7):1361-7. PubMed ID: 21463337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury.
    Ma X; Hua J; Mohamood AR; Hamad AR; Ravi R; Li Z
    Hepatology; 2007 Nov; 46(5):1519-29. PubMed ID: 17661402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.